Pauls Matthew sold Soleno Therapeutics Inc ($SLNO) shares once on the open market in the last 365 days for about $425,000. His most recent sale was on March 28, 2025. These sales rank 6,816th among 11,678 insiders in our database, well below the average of 8.6 million per person across 6.37 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | A | Common Stock | 25478 | $0.00 | 25,478.0000 | 6,103,813 | 9999.99% | 0.42% |
| Dec. 16, 2025 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | G | Common Stock | 128995 | $0.00 | 1,188,050.0000 | 216,462,161 | 9.79% | 0.06% |
| Dec. 14, 2025 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | F | Common Stock | 195705 | $6.92 | 1,317,045.0000 | 216,462,161 | 12.94% | 0.09% |
| Dec. 10, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | G | Common Stock | 9542 | $0.00 | 1,074.0000 | 3,061,681 | 89.88% | 0.31% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | M | Restricted Stock Units | 8493 | $0.00 | 16,985.0000 | 6,103,813 | 33.33% | 0.14% |
| Oct. 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | M | Restricted Stock Units | 2123 | $0.00 | 14,862.0000 | 6,103,813 | 12.50% | 0.03% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | M | Common Stock | 8493 | $0.00 | 8,493.0000 | 6,103,813 | 9999.99% | 0.14% |
| Oct. 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | M | Common Stock | 2123 | $0.00 | 10,616.0000 | 6,103,813 | 25.00% | 0.03% |
| Dec. 10, 2025 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | G | Common Stock | 23629 | $0.00 | 1,512,750.0000 | 216,462,161 | 1.54% | 0.01% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | A | Restricted Stock Units | 25478 | $0.00 | 25,478.0000 | 6,103,813 | 9999.99% | 0.42% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Pauls Matthew | Director | A | Stock Option | 77640 | $0.00 | 77,640.0000 | 6,103,813 | 9999.99% | 1.27% |
| June 5, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Pauls Matthew | Not found | A | Common Stock | 3991 | $0.00 | 10,491.0000 | 40,175,926 | 61.40% | 0.01% |
| March 28, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Pauls Matthew | Not found | M | Employee stock option (right to buy) | 5937 | $0.00 | 9,063.0000 | 40,175,926 | 39.58% | 0.01% |
| March 28, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Pauls Matthew | Not found | S | Common Stock | 5937 | $71.55 | 6,500.0000 | 40,175,926 | 47.74% | 0.01% |
| March 28, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Pauls Matthew | Not found | M | Common Stock | 5937 | $4.60 | 12,437.0000 | 40,175,926 | 91.34% | 0.01% |
| Dec. 12, 2024 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Common Stock | 400000 | $0.00 | 1,683,674.0000 | 211,847,651 | 31.16% | 0.19% |
| Dec. 13, 2024 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | F | Common Stock | 92593 | $3.21 | 1,591,081.0000 | 211,847,651 | 5.50% | 0.04% |
| Dec. 16, 2024 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | S | Common Stock | 54702 | $3.31 | 1,536,379.0000 | 211,847,651 | 3.44% | 0.03% |
| Dec. 12, 2024 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 900000 | $0.00 | 900,000.0000 | 211,847,651 | 9999.99% | 0.42% |
| June 6, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Pauls Matthew | Not found | A | Common Stock | 6500 | $0.00 | 6,500.0000 | 16,492,132 | 9999.99% | 0.04% |
| Dec. 28, 2023 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | G | Common Stock | 19000 | $0.00 | 1,283,674.0000 | 0 | 1.46% | 0.00% |
| Dec. 28, 2023 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | S | Common Stock | 84000 | $4.71 | 1,302,674.0000 | 0 | 6.06% | 0.00% |
| Dec. 14, 2023 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 14, 2023 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | A | Common Stock | 450000 | $0.00 | 1,386,674.0000 | 0 | 48.04% | 0.00% |
| Dec. 14, 2023 | Savara Inc | $SVRA | Pauls Matthew | CHIEF EXECUTIVE OFFICER | F | Common Stock | 109680 | $4.45 | 936,674.0000 | 0 | 10.48% | 0.00% |
| Aug. 15, 2023 | SOLENO THERAPEUTICS INC | $SLNO | Pauls Matthew | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 8,397,088 | 9999.99% | 0.18% |